In pancreatic ductal adenocarcinoma, Hayashi et al. [15] found that cell-in-cell structures predict prognosis, and associate with poorly-differentiated tumors, TP53 mutations, KRAS amplification and MYC amplification. Here, MYC is linked to pancreatic ductal adenocarcinoma.